Natasha Lorch

Natasha Lorch is an accomplished professional with extensive experience in public policy, strategic communications, and portfolio management within the pharmaceutical industry. Currently serving as the Head of Portfolio Strategy for Jazz Pharmaceuticals, Natasha leads a team focused on shaping investment and strategy decisions for the company's pipeline and in-line products. Previously, Natasha held senior roles at Jazz Pharmaceuticals in public policy, following the company's acquisition of GW Pharmaceuticals, where efforts were centered on cannabis policy and external affairs. Natasha's prior experience includes directorial positions at GW Pharmaceuticals and FTI Consulting, along with board membership at New City College. Natasha holds an MPhil from the University of Oxford and multiple degrees from prominent institutions, underscoring a strong academic foundation in politics, international affairs, and public health.